HeartBot II for Heart Disease Awareness in Women

(HeartBot II Trial)

This trial aims to determine if an AI-powered app called HeartBot II can enhance women's understanding of heart attacks. Researchers will divide participants into two groups: one will begin using the app immediately, while the other will wait 12 weeks. The app features short, interactive sessions with a chatbot. The study seeks women aged 25 and older, residing in the US, who are patients at University of California, San Francisco Health and possess a smartphone with internet access. Participants should not have a history of heart disease or work in healthcare.

As an unphased trial, this study offers participants the opportunity to contribute to innovative research and potentially improve heart health education for women.

The trial information does not specify whether you need to stop taking your current medications. It seems unlikely that you would need to stop, as the study focuses on using an app to improve awareness.

Research has shown that people responded positively to the HeartBot II program in other studies. Although the data does not specifically mention safety concerns, the app is designed for educational purposes, which typically indicates low risk. Users have learned about heart attacks in women through the app without any reported problems. This suggests that the program is likely safe and easy to use.¹²³⁴⁵

Researchers are excited about the HeartBot II Program because it aims to raise awareness of heart disease specifically in women, a group often underrepresented in heart health research. Unlike traditional treatments which focus on medication or surgery, HeartBot II uses an innovative digital approach to educate and empower women about heart health, potentially leading to more proactive management and prevention. This program could change the way heart disease is perceived and managed in women by making information more accessible and personalized.

Research has shown that HeartBot, an AI chatbot, can greatly enhance women's understanding of heart attack risks and symptoms. In this trial, participants in the HeartBot Intervention arm will use the chatbot to learn about heart health. Studies have found that people using HeartBot improved significantly in recognizing heart attack signs and knowing when to seek help. The chatbot covers important topics in a single session, aiming to effectively educate about heart health. Early results suggest that HeartBot could serve as a valuable tool for increasing heart health awareness among women.¹²³⁴⁶